Literature DB >> 12177726

The cost of an upper gastroduodenal endoscopy: an activity-based approach.

Ralph Crott1, Nicholaos Makris, Alan Barkun, Carlo Fallone.   

Abstract

The cost of medical procedures is often unknown, but is nevertheless crucial for setting reimbursement and health care policies. The cost of an upper gastroduodenal endoscopy was investigated in ambulatory adults in a large academic hospital in the province of Quebec, from the perspective of the hospital. An activity-based costing methodology was used to break down the procedure into a number of priory tasks, to which resources used at the department level (labour, equipment, materials) were allocated. The direct cost of performing an endoscopy ranged from $62 for an unsedated, unbiopsied patient to $89 for a sedated, biopsied patient. Not included in this amount were separate reimbursement fees of $15 for biopsy analysis and the $50 professional fee for the performing physician, which are charged directly to the Ministry of Health. Incorporating overall, general hospital fixed overhead costs raises the cost of the procedure substantially, by $41, as does the use of nonreusable biopsy forceps, which adds about $63 to the total cost of the procedure. Given the high proportion of overall, hospital-wide, overhead costs in the total cost of the procedure, allocation methods of these overhead costs in current hospital accounting systems should be improved to obtain a more precise estimate of the full cost of upper gastroduodenal endoscopy.

Entities:  

Mesh:

Year:  2002        PMID: 12177726     DOI: 10.1155/2002/548616

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  9 in total

1.  Activity-based costing evaluation of [18F]-fludeoxyglucose production.

Authors:  Bruno Krug; Annie Van Zanten; Anne-Sophie Pirson; Ralph Crott; Thierry Vander Borght
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-21       Impact factor: 9.236

2.  The Stretta procedure versus proton pump inhibitors and laparoscopic Nissen fundoplication in the management of gastroesophageal reflux disease: a cost-effectiveness analysis.

Authors:  Dan Comay; Viviane Adam; Ediardo B da Silveira; Wendy Kennedy; Serge Mayrand; Alan N Barkun
Journal:  Can J Gastroenterol       Date:  2008-06       Impact factor: 3.522

3.  The costs of colonoscopy in a Canadian hospital using a microcosting approach.

Authors:  Nour Sharara; Viviane Adam; Ralph Crott; Alan N Barkun
Journal:  Can J Gastroenterol       Date:  2008-06       Impact factor: 3.522

Review 4.  Guideline on screening for esophageal adenocarcinoma in patients with chronic gastroesophageal reflux disease.

Authors:  Stéphane Groulx; Heather Limburg; Marion Doull; Scott Klarenbach; Harminder Singh; Brenda J Wilson; Brett Thombs
Journal:  CMAJ       Date:  2020-07-06       Impact factor: 8.262

5. 

Authors:  Stéphane Groulx; Heather Limburg; Marion Doull; Scott Klarenbach; Harminder Singh; Brenda J Wilson; Brett Thombs
Journal:  CMAJ       Date:  2020-11-23       Impact factor: 8.262

6.  Gender-related differences in upper gastrointestinal endoscopic findings: an assessment of 4,700 cases from Iran.

Authors:  Amir Hossein Boghratian; Mohammad Hossein Hashemi; Ali Kabir
Journal:  J Gastrointest Cancer       Date:  2009

7.  Convolutional neural network-based system for endocytoscopic diagnosis of early gastric cancer.

Authors:  Hiroto Noda; Mitsuru Kaise; Kazutoshi Higuchi; Eriko Koizumi; Keiichiro Yoshikata; Tsugumi Habu; Kumiko Kirita; Takeshi Onda; Jun Omori; Teppei Akimoto; Osamu Goto; Katsuhiko Iwakiri; Tomohiro Tada
Journal:  BMC Gastroenterol       Date:  2022-05-12       Impact factor: 2.847

8.  Usefulness of Noninvasive Predictors of Oesophageal Varices in Black African Cirrhotic Patients in Côte d'Ivoire (West Africa).

Authors:  Alassan Kouamé Mahassadi; Fulgence Yao Bathaix; Constant Assi; Aboubacar Demba Bangoura; Emile Allah-Kouadio; Henriette Ya Kissi; Abdoulaye Touré; Stanislas Doffou; Issa Konaté; Alain Koffi Attia; Mathieu Benoit Camara; Thérèse Aya Ndri-Yoman
Journal:  Gastroenterol Res Pract       Date:  2012-07-22       Impact factor: 2.260

Review 9.  Treatment costs to prevent or treat upper gastrointestinal adverse events associated with NSAIDs.

Authors:  Elham Rahme; Alan N Barkun; Viviane Adam; Marc Bardou
Journal:  Drug Saf       Date:  2004       Impact factor: 5.228

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.